Progyny Q2 revenue $332.9M (+9.5% YoY); raises FY2025 guidance on strong member engagement

Progyny, Inc.

2025-Q2 EPS reported $0.36 revenue$656,912,000

Q2 revenue $332.9M, up 9.5% YoY; ex-large-client transition revenue grew 18%.
Adjusted EBITDA $57.9M (17.4% margin); adjusted EPS $0.48 vs $0.43 prior year.
Raises FY2025 revenue guidance to $1.235B-$1.270B; adjusted EPS guidance to $1.70-$1.78.
Record H1 operating cash flow $105.3M; no debt; entered $200M revolver (undrawn).
Fertility clients grew to 542 from 463 YoY; ART cycles 16,938 (+8.8% YoY).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.